The burden and management of crystal meth use

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 12, 2008, Pages 1537-1539

  Buxton, Jane A ^a   Dove, Naomi A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; METHAMPHETAMINE; CENTRAL STIMULANT AGENT;

COGNITIVE THERAPY; HIGH RISK POPULATION; PREVALENCE; REVIEW; SUBSTANCE ABUSE; SYMPTOMATOLOGY; CANADA; COST OF ILLNESS; DRUG ABUSE; HIGH RISK BEHAVIOR; HUMAN;

AMPHETAMINE-RELATED DISORDERS; CANADA; CENTRAL NERVOUS SYSTEM STIMULANTS; COST OF ILLNESS; HUMANS; METHAMPHETAMINE; RISK-TAKING;

EID: 45549100526     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071234     Document Type: Review

References (23)

1. Anglin MD, Burke C, Perrochet B, et al. History of the methamphetamine problem. J Psychoactive Drugs 2000;32:137-41.
2. Canadian Centre on Substance Abuse. Memamphetamine fact sheet. Ottawa: The Centre; 2005. Available: www.ccsa.ca/NR/rdonlyres/A378E355-BB39- 45FB-BDB8-FB751EDBAFFD/0/ccsa0111342005.pdf (accessed 2008 Apr 15).
3. Curtis EK. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Dent 2006;54:125-9.
4. United Nations Office on Drugs and Crime. World drug report 2007. New York: United Nations Publications; 2007. Available: www.unodc.org/documents/ data-and-analysis/WDR-2007-exsum.pdf (accessed 2008 Apr 15).
5. Adlaf EM, Begin P, Sawka E (editors). Canadian Addiction Survey: A national survey of Canadians' use of alcohol and other drugs: prevalence of use and related harms: highlights. Ottawa: The Canadian Centre on Substance Abuse; 2005. Available: www.ccsa.ca/NR/rdonlyres/B2C820A2-C987-4F08-8605-2BE999FE4DEC/ 0/ccsa0048042004.pdf (accessed 2008 Apr 15)
6. Substance Abuse and Mental Health Services Administration. Results from the 2005 national survey on drug use and health: national Findings. Rockville (MD): The Office of Applied Studies; 2006.
7. Dunn M, Degenhardt L, Campbell G, et al. Australian trends in ecstasy and related drug markets 2006: findings from the ecstasy and related drugs reporting system. Sydney (Australia): National Drug and Alcohol Research Centre, University of New South Wales; 2007.
8. European Monitoring Centre for Drugs and Drug Addiction Annual report 2006: the state of the drugs problem in Europe. Available: http://ar2006.emcdda. europa.eu/en/page008-en.html (accessed 2008 Apr 15).
9. Adlaf EM, Paglia-Boak A. Drug use among Ontario students 1977-2005. Toronto: Centre for Addictions and Mental Health; 2005. Available: www.camh.net/Research/Areas_of_research/Population_Life_Course_Studies/OSDUS/ OSDUS2005_DrugDetailed_final.pdf (accessed 2008 Apr 15).
10. The McCreary Centre Society. Healthy youth development: highlights from the 2003 Adolescent Health Survey III. Available: www.mcs.bc.ca/pdf/AHS- 3_provincial.pdf (accessed 2008 Apr 29).
11. Youth risk behavior surveillance - United States, 2005. MMWR Surveill Summ 2006;55:1-108.
12. Duff C, Chow C, Ryan E, et al. Vancouver youth drug reporting system: 2006 preliminary findings. Vancouver: Vancouver Coastal Health; 2006.
13. Lampinen TM, McGhee D, Martin I. Increased risk of "club" drug use among gay and bisexual high school students in British Columbia. J Adolesc Health 2006;38:458-61.
14. Martin I, Lampinen TM, McGhee D. Methamphetamine use among marginalized youth in British Columbia. Can J Public Health 2006;97:320-4.
15. Bolding G, Hart G, Sherr L, et al. Use of crystal methamphetamine among gay men in London. Addiction 2006;101:1622-30.
16. Bungay V, Malchy L, Buxton JA, et al. Life with jib: a snapshot of street youth's use of crystal methamphetamine. Addiction Reaserch and Theory 2006; 14:235-51.Available: www.hawaii.edu/hivandaids/ Life_with_Jib_A_Snapshot_of_Street_Youth_s_Use_of_Crystal_Methamphetamine.pdf (accessed 2008 Apr 15).
17. Saul D. Western Canadian summit on methamphetamines: bringing together practitioners, policy makers and researchers. Vancouver: Vancouver Coastal Health; 2005. Available: www.sfu.ca/dialog/Meth_Booklet_2005_Final.pdf (accessed 2008 Apr 24).
18. Goldfrank LR, FlomenbaumNE, Lewin NA, et al, editors. Goldfrank's toxicologic emergencies. 7th ed. McGraw-Hill; 2002. p. 1028.
19. Roll JM, Petty NM, Stitzer ML, et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006;163:1993-9.
20. Rawson RA, McCann MJ, Flammino, et al. A comparison of contingency management and cognitive-behavioural approaches for stimulant-dependent individuals. Addiction 2006;101:267-74.
21. Grabowski J, Shearer J, Merrill J, et al. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 2004;29:1439-64.
22. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev 2001;(4):CD003022.
23. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A Multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004;99:708-17.